Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

High-resolution PET-CT Imaging for Intraoperative Margin Assessment in Early-stage Breast Cancer: a Prospective Multicentric Interventional Clinical Study

NCT04999917 is registered in ClinicalTrials.gov with XEOS Medical as lead sponsor.

NCT NCT04999917
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04999917 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
High-resolution PET-CT Imaging for Intraoperative Margin Assessment in Early-stage Breast Cancer: a Prospective Multicentric Interventional Clinical Study
Lead sponsor
XEOS Medical
Phase
Not applicable
Overall status
Completed
Start date
June 17, 2022
Completion date
April 3, 2025
Enrollment
206 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

breast cancer, breast cancer in situ, breast cancer invasive